Rybelsus, Mounjaro, Wegovy: India's weight-loss drug boom and the risks behind it

India's obesity epidemic drives surge in demand for anti-obesity drugs like Rybelsus and Mounjaro, despite high costs and concerns over misuse. These drugs, originally designed for diabetes, are now seen as quick fixes for weight loss, but experts warn of potential health risks and the importance of sustainable habits. The boom in obesity is also reshaping medicine, with some surgeons requiring patients to try these drugs before surgery. However, doctors urge caution and emphasize the need for a balanced approach to health. The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.